THE PHARMACOKINETICS OF FLUCONAZOLE DURING HEMODIALYSIS IN UREMIC PATIENTS

被引:0
|
作者
OONO, S [1 ]
TABEI, K [1 ]
TETSUKA, T [1 ]
ASANO, Y [1 ]
机构
[1] JICHI MED SCH,DEPT MED,DIV NEPHROL,3311-1 MINAMIKAWACHI MACHI,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
关键词
FLUCONAZOLE; HEMODIALYSIS; FUNGAL INFECTION; UREMIA PHARMACOKINETICS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have studied the pharmacokinetics of fluconazole in five patients on long-term haemodialysis. The single-pass extraction rate of the dialyzer was 59 (3.5)% (n = 4), and the serum concentration was reduced by haemodialysis for 3 or 4 h by 26 (3.2)% (n = 5) and 39 (2.2)% (n = 9) respectively. The estimated amount extracted by a dialysis of 4 h was 33 (3.2)% (n = 4) of the dose. During repeated administration the serum fluconazole concentration increased, reaching a plateau at about 4 times the peak concentration after the first dose. After discontinuing administration the serum fluconazole concentration fell by 25% in every 3 h dialysis session. We conclude that fluconazole should be given in the usual dose of 100 or 200 mg at the end of every haemodialysis session.
引用
收藏
页码:667 / 670
页数:4
相关论文
共 50 条
  • [1] NETILMICIN PHARMACOKINETICS IN UREMIC PATIENTS UNDERGOING HEMODIALYSIS
    SCATIZZI, A
    BASILE, C
    STRIPPOLI, P
    DIMAGGIO, A
    ORBELLO, G
    LODESERTO, C
    TRIARICO, A
    MINGRONE, G
    LONGO, S
    CURINO, E
    COVIELLO, F
    CHEMIOTERAPIA, 1986, 5 (05): : 327 - 329
  • [2] CLINICAL PHARMACOKINETICS OF CEFAMANDOLE IN UREMIC PATIENTS UNDERGOING HEMODIALYSIS
    GAMBERTOGLIO, JG
    AZIZ, NS
    LIN, ET
    GRAUSZ, H
    BENET, LZ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1978, 23 (01) : 114 - 114
  • [3] PHOSPHATE IN UREMIC PATIENTS DURING AND BETWEEN HEMODIALYSIS
    HILLION, D
    HAAS, T
    CLINICAL NEPHROLOGY, 1994, 42 (04) : 275 - 275
  • [4] SERUM GASTRIN LEVEL IN UREMIC PATIENTS DURING HEMODIALYSIS
    POINTNER, H
    FLEGEL, U
    SCHMIDT, P
    ZAZGORNI.J
    KOPSA, H
    WALDHAUS.W
    WIENER KLINISCHE WOCHENSCHRIFT, 1974, 86 (22) : 696 - 699
  • [5] PLASMA LIPID STUDIES OF UREMIC PATIENTS DURING HEMODIALYSIS
    TSALTAS, TT
    FRIEDMAN, EA
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1968, 21 (05): : 430 - &
  • [6] CHANGES IN INSULIN BINDING DURING HEMODIALYSIS IN UREMIC PATIENTS
    MILUTINOVIC, S
    BREYER, D
    MOLNAR, V
    STEFOVIC, A
    JANKOVIC, N
    SKRABALO, Z
    ROCIC, B
    NEPHRON, 1985, 41 (04) : 307 - 313
  • [7] Fluconazole pharmacokinetics in burn patients
    Boucher, BA
    King, SR
    Wandschneider, HL
    Hickerson, WL
    Hanes, SD
    Herring, VL
    Canada, TW
    Hess, MM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 930 - 933
  • [8] HEMODIALYSIS OF CHRONICAL UREMIC PATIENTS
    SIMONITI, J
    ZDRAVSTVENI VESTNIK, 1974, 43 (01): : 35 - 37
  • [9] HEMODIALYSIS OF ACETAMINOPHEN IN UREMIC PATIENTS
    MARBURY, TC
    WANG, LH
    LEE, CS
    ASHOURI, O
    CLINICAL RESEARCH, 1979, 27 (05): : A738 - A738
  • [10] HEMODIALYSIS OF ACETAMINOPHEN IN UREMIC PATIENTS
    MARBURY, TC
    WANG, LH
    LEE, CS
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1980, 3 (05): : 263 - 266